OCULNasdaqPharmaceutical PreparationsFiscal year ends December 31
OCULAR THERAPEUTIX, INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$6.29−0.58 (-8.44%)
Close on Oct 19, 2026
- Market cap
- $1.41B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Ocular Therapeutix's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 14, 2026 | Oct 16, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 3, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2026 | Jun 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 5, 2026 | SEC EDGAR |
| Current report | 8-K | May 5, 2026 | May 5, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 11, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2026 | Feb 27, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 5, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 5, 2026 | Feb 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 20, 2026 | Jan 23, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 18, 2025 | Dec 18, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 5, 2025 | Dec 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 4, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2025 | Nov 4, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 30, 2025 | Sep 30, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 30, 2025 | Sep 30, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 5, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2025 | Aug 5, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2025 | Jun 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 5, 2025 | SEC EDGAR |
| Current report | 8-K | May 5, 2025 | May 5, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 11, 2025 | Apr 29, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 3, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2025 | Mar 3, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 11, 2025 | Feb 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 4, 2024 | Oct 9, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 29, 2024 | Sep 3, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 7, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2024 | Aug 7, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2024 | Jun 14, 2024 | SEC EDGAR |
| Current report | 8-K | May 29, 2024 | Jun 3, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 7, 2024 | SEC EDGAR |
| Current report | 8-K | May 7, 2024 | May 7, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 12, 2024 | Apr 29, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 14, 2024 | Apr 18, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 28, 2024 | Mar 29, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 11, 2024 | SEC EDGAR |